Ideas Discussions Themes Map Live Ask AI

All beneficiaries

company

GSK

Information not available

The entity GSK could not be verified based on the provided research brief.

Ideas that could help GSK

IL-1β Trained Immunity Adjuvant Potency AssayWhy it helps: GSK is the world leader in adjuvant technology (AS01, AS03, MPL); a trained-immunity potency assay would strengthen their adjuvant platform characterization and IP position.
GWAS Lead-SNP Causal-Gene AnnotatorWhy it helps: Its human-genetics team explicitly uses GWAS and functional genomics for target validation; mechanism-annotated causal-gene calls would prioritize which hits advance to experimental follow-up.
AirwayNorm: Normative Scoring Module for Rat Inhalation HistopathologyWhy it helps: Large inhaled asthma/COPD portfolio; standardized goblet-cell and ciliary metrics grounded in normative data would reduce inter-study variability in its respiratory safety programs.
Conserved-Patch Epitope Mapper for viral glycoprotein familiesWhy it helps: Runs structure-based vaccine programs; conserved patch discovery adds a target-nomination input for viral vaccine candidates.

Recent research, turned into concrete, commercially plausible innovation ideas — each with an interactive prototype you can try.

Explore

Ideas
Discussions
Themes
Live
Research
Map
Personas
Who benefits
Ask AI

For you

For researchers
For industry
For investors

Learn more

About
How it works
FAQ

Account

Sign in
Your space
Your stream
Your digest
Your contexts
Your data

© 2026 SeedlabsRecent research, turned into shippable ideas.